MIR4665

Across TCGA pan-cancer cohorts, MIR4665 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR4665’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where MIR4665 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4665 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

COAD, STAD, and KIRC are the cancer types where MIR4665 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4665 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.508	.003	5	view →
STAD	Male	II,III,IV	+0.958	.026	2	view →
KIRC	Male	II,III,IV	−0.213	.038	2	view →
LIHC	Female	All	+0.160	.019	2	view →
LUSC	Male	All	+0.210	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR4665–COAD

Open the COAD breakdown →